Prudential Financial Inc. Raises Position in Danaher Corporation (DHR)

Prudential Financial Inc. increased its stake in shares of Danaher Corporation (NYSE:DHR) by 5.2% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,628,584 shares of the conglomerate’s stock after purchasing an additional 130,621 shares during the period. Prudential Financial Inc. owned 0.38% of Danaher Corporation worth $225,480,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of the stock. Vanguard Group Inc. raised its position in shares of Danaher Corporation by 1.3% during the 2nd quarter. Vanguard Group Inc. now owns 41,488,407 shares of the conglomerate’s stock worth $3,501,206,000 after purchasing an additional 520,776 shares during the last quarter. BlackRock Inc. raised its position in shares of Danaher Corporation by 3.2% during the 2nd quarter. BlackRock Inc. now owns 39,201,798 shares of the conglomerate’s stock worth $3,308,239,000 after purchasing an additional 1,233,876 shares during the last quarter. FMR LLC raised its position in shares of Danaher Corporation by 0.9% during the 2nd quarter. FMR LLC now owns 19,624,350 shares of the conglomerate’s stock worth $1,656,100,000 after purchasing an additional 183,183 shares during the last quarter. Parnassus Investments CA raised its position in shares of Danaher Corporation by 0.3% during the 3rd quarter. Parnassus Investments CA now owns 9,796,584 shares of the conglomerate’s stock worth $840,351,000 after purchasing an additional 29,381 shares during the last quarter. Finally, Geode Capital Management LLC raised its position in shares of Danaher Corporation by 6.0% during the 1st quarter. Geode Capital Management LLC now owns 5,815,659 shares of the conglomerate’s stock worth $496,687,000 after purchasing an additional 329,458 shares during the last quarter. Hedge funds and other institutional investors own 75.56% of the company’s stock.

Several brokerages have weighed in on DHR. Zacks Investment Research upgraded Danaher Corporation from a “hold” rating to a “buy” rating and set a $97.00 price target for the company in a report on Thursday, October 5th. Cowen and Company reiterated a “buy” rating and issued a $90.00 price target on shares of Danaher Corporation in a report on Wednesday, October 4th. Jefferies Group LLC reiterated a “buy” rating and issued a $95.00 price target on shares of Danaher Corporation in a report on Friday, August 4th. Goldman Sachs Group, Inc. (The) reiterated a “neutral” rating and issued a $83.00 price target on shares of Danaher Corporation in a report on Tuesday, September 26th. Finally, Robert W. Baird boosted their price target on Danaher Corporation from $87.00 to $97.00 and gave the company an “outperform” rating in a report on Friday, October 20th. One analyst has rated the stock with a sell rating, four have issued a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. Danaher Corporation currently has a consensus rating of “Buy” and an average target price of $93.31.

In other Danaher Corporation news, SVP Daniel Raskas sold 37,870 shares of the business’s stock in a transaction on Thursday, November 16th. The shares were sold at an average price of $93.33, for a total value of $3,534,407.10. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, CFO Daniel L. Comas sold 88,184 shares of the business’s stock in a transaction on Monday, October 23rd. The stock was sold at an average price of $91.02, for a total transaction of $8,026,507.68. Following the completion of the transaction, the chief financial officer now owns 227,816 shares in the company, valued at approximately $20,735,812.32. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 317,498 shares of company stock valued at $28,838,801. 12.20% of the stock is owned by corporate insiders.

WARNING: This piece was posted by Sports Perspectives and is the property of of Sports Perspectives. If you are accessing this piece on another website, it was illegally stolen and reposted in violation of United States & international trademark & copyright law. The legal version of this piece can be accessed at https://sportsperspectives.com/2017/11/21/prudential-financial-inc-raises-position-in-danaher-corporation-dhr.html.

Shares of Danaher Corporation (NYSE:DHR) opened at $93.68 on Tuesday. The company has a current ratio of 1.43, a quick ratio of 1.00 and a debt-to-equity ratio of 0.42. Danaher Corporation has a 12-month low of $76.27 and a 12-month high of $93.86. The firm has a market cap of $65,020.00, a price-to-earnings ratio of 23.99, a P/E/G ratio of 2.22 and a beta of 1.02.

Danaher Corporation (NYSE:DHR) last announced its quarterly earnings results on Thursday, October 19th. The conglomerate reported $1.00 earnings per share for the quarter, topping analysts’ consensus estimates of $0.95 by $0.05. Danaher Corporation had a net margin of 13.36% and a return on equity of 11.29%. The firm had revenue of $4.53 billion during the quarter, compared to analysts’ expectations of $4.47 billion. During the same period in the prior year, the company earned $0.87 EPS. The firm’s revenue was up 9.6% on a year-over-year basis. analysts anticipate that Danaher Corporation will post 3.99 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which was paid on Friday, October 27th. Investors of record on Friday, September 29th were given a dividend of $0.14 per share. The ex-dividend date of this dividend was Thursday, September 28th. This represents a $0.56 dividend on an annualized basis and a yield of 0.60%. Danaher Corporation’s dividend payout ratio (DPR) is 16.67%.

Danaher Corporation Company Profile

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR).

Institutional Ownership by Quarter for Danaher Corporation (NYSE:DHR)

Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply